Waypoint Wealth Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Waypoint Wealth Counsel's ABBV Position: Q3 2026 in Review
Waypoint Wealth Counsel reduced its AbbVie (ABBV) stake by 1.6% in Q3 2026, selling an estimated $5.9K and leaving 1,437 shares worth $376K. The position accounts for 0.22% of the portfolio, ranked #85.
Waypoint Wealth Counsel first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. The position peaked at $896K in Q4 2022. 4,250 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Waypoint Wealth Counsel held 1,437 shares of AbbVie worth $376K as of Q3 2026.
- Waypoint Wealth Counsel sold 23 AbbVie shares in Q3 2026, an estimated $5.9K.
- AbbVie made up 0.22% of Waypoint Wealth Counsel's portfolio in Q3 2026, its #85 holding.
- Waypoint Wealth Counsel first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
- Waypoint Wealth Counsel's AbbVie position peaked at $896K in Q4 2022.
- 4,250 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Waypoint Wealth Counsel's 13F filing for Q3 2026, filed 22 Oct 2026.